25 Stocks Moving In Friday’s Mid-Day Session
Gainers
Helbiz, Inc. (NASDAQ: HLBZ) shares jumped 92.7% to $17.35 after the company announced its media unit has entered into an agreement with FOX Networks to broadcast the Italian Serie B championship across the USA and the Caribbean.
Syros Announces First Patient Dosed In SELECT-AML-1 Trial Of Tamibarotene In Combination With Venetoclax And Azacitidine In Newly Diagnosed Unfit AML
Syros Pharmaceuticals (NASDAQ:SYRS), a leader in the development of medicines that control the expression of genes, today announced that the first patient has been dosed in the SELECT-AML-1 clinical trial of
Stocks That Hit 52-Week Lows On Friday
On Friday morning, 155 companies achieved new lows for the year.
The Daily Biotech Pulse: J&J Announces CEO Transition, FibroGen’s Roxadustat Approved In Europe, GeoVax, Sorrento Announce COVID-19 Vaccine Data
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 19)
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios’ Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 17)
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 16)
Syros Pharma US Patent & Trademark Office Abstract For Co.’s ‘Compositions of cyclin dependent kinase 7 (CDK7) inhibitor’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=6686&f=G&l=50&d=PTXT&p=134&S1=20210810&OS=20210810&RS=20210810
Syros Pharmaceuticals Sponsored Study Titled ‘A Study for Oral SY-2101 for Participants With Acute Promyelocytic Leukemia’ Posted To ClinicalTrials.Gov; Study Not Yet Recruiting
https://clinicaltrials.gov/ct2/show/NCT04996030